More medical news from Wall Street Journal
NantKwest Gives Biotech Another Big IPO
Wall Street Journal : July 28, 2015, 8:28 am
These days, a biotech company doesn’t need an approved drug to be worth several billion dollars.
Merck Earnings Hurt by Arthritis Drug Knockoffs
Wall Street Journal : July 28, 2015, 7:52 am
Low-cost knockoffs of the arthritis treatment Remicade in Europe hurt Merck & Co.’s second-quarter sales and earnings, a harbinger of the pressure facing sellers of costly biotechnology drugs in coming years.
New Strategies Deployed in Abortion Battle
Wall Street Journal : July 28, 2015, 7:49 am
As the fight between antiabortion activists and abortion-rights supporters about the use of fetal tissue in medical research enters its third week, both sides have shifted tactics in their battle.
U.S. Health-Spending Growth Jumped to 5.5% in 2014
Wall Street Journal : July 28, 2015, 6:20 am
Growth in national health spending, which had dropped to historic lows in recent years, has snapped back and is set to continue at a faster pace over the next decade, federal actuaries said.
Gilead Sales Soar on Hepatitis Drugs
Wall Street Journal : July 28, 2015, 1:22 am
Gilead Sciences said its two key hepatitis C drugs, Sovaldi and Harvoni, generated about $4.9 billion in sales in the second quarter, topping Wall Street estimates.